聖湘生物(688289.SH):陳文義所持2224.1466萬股存在被司法凍結的情形
格隆匯 4 月 30日丨聖湘生物(688289.SH)公佈,公司通過中國證券登記結算有限責任公司系統查詢,獲悉公司股東陳文義所持公司2224.1466萬股股份存在被司法凍結的情形。
經向股東征詢,此次股份被司法凍結系其個人與凍結申請人之間的借款合同糾紛。
一是,凍結申請人:蕪湖鵬華叁號投資中心(有限合夥);被凍結人:陳文義;凍結機關:湖南省長沙市中級人民法院;被凍結股份是否為限售流通股:是;被凍結股份數量:22,101,466股,其中8,047,935股為輪候凍結;
陳文義持有公司股份總數:22,241,466股,佔公司總股本比例5.56%,此次被凍結股份數量佔公司總股本比例:5.53%。
二是,凍結申請人:株洲市天元區國信財富小額貸款有限公司;被凍結人:陳文義;凍結機關:湖南省株洲市天元區人民法院;被凍結股份是否為限售流通股:是;被凍結股份數量:140,000股;
陳文義持有公司股份總數:22,241,466股,佔公司總股本比例5.56%,本次被凍結股份數量佔公司總股本比例:0.04%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.